Apo-Sulfinpyrazone en es it fr

Apo-Sulfinpyrazone Brand names, Apo-Sulfinpyrazone Analogs

Apo-Sulfinpyrazone Brand Names Mixture

  • No information avaliable

Apo-Sulfinpyrazone Chemical_Formula


Apo-Sulfinpyrazone RX_link


Apo-Sulfinpyrazone fda sheet

Apo-Sulfinpyrazone msds (material safety sheet)

Apo-Sulfinpyrazone Synthesis Reference

No information avaliable

Apo-Sulfinpyrazone Molecular Weight

404.483 g/mol

Apo-Sulfinpyrazone Melting Point

136-137 oC

Apo-Sulfinpyrazone H2O Solubility

31.2 mg/L

Apo-Sulfinpyrazone State


Apo-Sulfinpyrazone LogP


Apo-Sulfinpyrazone Dosage Forms

100-mg tablets and 200-mg capsules for oral administration

Apo-Sulfinpyrazone Indication

For the treatment of gout and gouty arthritis.

Apo-Sulfinpyrazone Pharmacology

Sulfinpyrazone's pharmacologic activity is the potentiation of the urinary excretion of uric acid. It is useful for reducing the blood urate levels in patients with chronic tophaceous gout and acute intermittent gout, and for promoting the resorption of tophi.

Apo-Sulfinpyrazone Absorption

No information avaliable

Apo-Sulfinpyrazone side effects and Toxicity

Symptoms of overdose include nausea, vomiting, diarrhea, epigastric pain, ataxia, labored respiration, convulsions, coma. Possible symptoms, seen after overdosage with other pyrazolone derivatives: anemia, jaundice, and ulceration.

Apo-Sulfinpyrazone Patient Information

No information avaliable

Apo-Sulfinpyrazone Organisms Affected

Humans and other mammals